| 000 | 01530 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513094925.0 | ||
| 264 | 0 | _c19961122 | |
| 008 | 199611s 0 0 eng d | ||
| 022 | _a0022-1767 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBaum, L L | |
| 245 | 0 | 0 |
_aHIV-1 gp120-specific antibody-dependent cell-mediated cytotoxicity correlates with rate of disease progression. _h[electronic resource] |
| 260 |
_bJournal of immunology (Baltimore, Md. : 1950) _cSep 1996 |
||
| 300 |
_a2168-73 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAcquired Immunodeficiency Syndrome _xepidemiology |
| 650 | 0 | 4 |
_aAntibodies, Viral _xphysiology |
| 650 | 0 | 4 | _aAntibody-Dependent Cell Cytotoxicity |
| 650 | 0 | 4 | _aCytotoxicity Tests, Immunologic |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 |
_aHIV Envelope Protein gp120 _xblood |
| 650 | 0 | 4 |
_aHIV Seropositivity _xepidemiology |
| 650 | 0 | 4 | _aHIV Seroprevalence |
| 650 | 0 | 4 |
_aHIV-1 _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aViremia _xepidemiology |
| 700 | 1 | _aCassutt, K J | |
| 700 | 1 | _aKnigge, K | |
| 700 | 1 | _aKhattri, R | |
| 700 | 1 | _aMargolick, J | |
| 700 | 1 | _aRinaldo, C | |
| 700 | 1 | _aKleeberger, C A | |
| 700 | 1 | _aNishanian, P | |
| 700 | 1 | _aHenrard, D R | |
| 700 | 1 | _aPhair, J | |
| 773 | 0 |
_tJournal of immunology (Baltimore, Md. : 1950) _gvol. 157 _gno. 5 _gp. 2168-73 |
|
| 999 |
_c8754258 _d8754258 |
||